Aphria Inc  

(Public, CVE:APH)   Watch this stock  
Find more results for APH
-0.06 (-1.56%)
Delayed:   12:30PM EDT
CVE data delayed by 15 mins - Disclaimer
Currency in CAD
Range 3.72 - 3.93
52 week 1.04 - 4.04
Open 3.85
Vol / Avg. 964,629.00/1.62M
Mkt cap 373.16M
P/E 906.47
Div/yield     -
EPS 0.00
Shares 96.69M
Beta     -
Inst. own     -
Jan 16, 2017
Q2 2017 Aphria Inc Earnings Release (Estimated) - 9:30AM EST - Add to calendar
Oct 7, 2016
Q1 2017 Aphria Inc Earnings Release

Key stats and ratios

Q2 (May '16) 2016
Net profit margin 46.90% 4.72%
Operating margin -0.27% -12.93%
EBITD margin - -1.59%
Return on average assets 15.94% 1.57%
Return on average equity 16.67% 1.65%
CDP Score - -


269 Erie St S, PO Box 20009

Website links


Aphria Inc., formerly Black Sparrow Capital Corp., is a Canada-based company, which is engaged in producing and selling medical marijuana through retail sales and wholesale channels. The Company's retail sales are primarily sold through the Company's online store, as well as telephone orders. Its wholesale shipments are sold to other Medical Purposes Regulations (MMPR) Licensed Producers. It offers medical cannabis of various strains, including Kusawa, Tamaracouta, Panache, Churchill and Iroquois. The Company is also engaged in the research and development, and commercial production of cannabis oil. Its cannabis oil products will include Champlain, Rideau and Capilano. Its cannabis oil products will be available in approximately 60 milliliter bottles. Its subsidiaries include Pure Natures Wellness Inc., which is engaged in producing and selling medical marijuana, and Cannway Pharmaceuticals Ltd., which specializes in providing support services to veterans and first responders.